查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1477411

野生動物保健市場 - 全球產業規模、佔有率、趨勢、機會和預測，按動物類型、產品、管理途徑、最終用途區域和競爭細分，2019-2029F

Wildlife Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Product, By Route of Administration, By End-Use Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年，全球野生動物健康市場估值為24.5 億美元，預計到2029 年，預測期內將實現強勁成長，複合年成長率為8.75%。領域的一個新興行業。隨著人們對人類健康、動物健康和環境完整性之間錯綜複雜關係的認知不斷增強，近年來該市場出現了顯著成長。這種擴張的主要驅動力之一是認知到人畜共患疾病所構成的威脅，這種疾病可以從動物傳染給人類，埃博拉、SARS 等疫情以及最引人注目的COVID-19 大流行就證明了這一點。因此，對旨在監測、診斷和管理野生動物種群疾病的野生動物健康產品和服務的需求激增。這包括疾病監測技術，例如遙感設備和分子診斷，以及野生動物物種的創新疫苗和治療方法。

市場概況
預測期 2025-2029
2023 年市場規模 24.5億美元
2029 年市場規模 40.6億美元
2024-2029 年複合年成長率 8.75%
成長最快的細分市場 哺乳動物
最大的市場 北美洲

整體的「同一個健康」方法已經發生範式轉變，強調人類、動物和環境健康的相互連結。這種方法強調了保護生物多樣性和生態系統完整性作為疾病預防和控制關鍵組成部分的重要性。因此，全球野生動物健康市場不僅包括生物醫學干預措施，還包括生態系統管理策略，例如棲息地恢復、野生動物保護和野生動物貿易監管。

該市場的特點是利益相關者多元化，包括政府機構、非營利組織、研究機構、製藥公司和野生動物保護團體，所有這些機構在製定政策、資助研究和實施干預措施方面都發揮著至關重要的作用。然而，市場也面臨挑戰，包括資金限制、監管障礙以及與不同野生動物物種和生態系統合作的固有複雜性。此外，圍繞著野生動物研究和管理的倫理考慮，例如動物福利和原住民權利，提出了需要仔細審議的重要問題。

主要市場促進因素

人畜共患病威脅日益增加

技術進步

培養一種健康方法

主要市場挑戰

資金限制

監管障礙

數據限制

主要市場趨勢

對人畜共通傳染病威脅的認知不斷提高

增加公共和私人投資

細分市場洞察

動物類型見解

產品洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球野生動物健康市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型（哺乳類、鳥類、魚類、爬蟲類、兩棲類）
    • 依產品（藥品、設備和消耗品）
    • 依給藥途徑（口服、注射、其他）
    • 依最終用途（動物園、野生動物保護區、野生動物救援和復健中心、其他）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖
    • 依動物類型
    • 按產品分類
    • 依給藥途徑
    • 按最終用途
    • 按地區

第 6 章：亞太地區野生動物健康市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型
    • 按產品分類
    • 依給藥途徑
    • 按最終用途
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第 7 章：歐洲野生動物健康市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型
    • 按產品分類
    • 依給藥途徑
    • 按最終用途
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 8 章：北美野生動物健康市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型
    • 按產品分類
    • 依給藥途徑
    • 按最終用途
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 9 章：南美洲野生動物保健市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型
    • 按產品分類
    • 依給藥途徑
    • 按最終用途
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲野生動物健康市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依動物類型
    • 按產品分類
    • 依給藥途徑
    • 按最終用途
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 埃及

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 最近的發展
  • 產品發布（如有）
  • 併購（如有）

第 13 章：全球野生動物健康市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • Boehringer Ingelheim International GmbH
  • NexGen Pharmaceuticals LLC
  • Virbac SA
  • Dong Bang Co., Ltd.
  • Pneu-Dart Inc.
  • DANiNJECT
  • Genia Inc.
  • Wedgewood Pharmacy LLC
  • The Pet Apothecary
  • Taylors Pharmacy LLC

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23981

Global Wildlife Health Market was valued at USD 2.45 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.75% through 2029. The Global Wildlife Health Market represents a burgeoning sector at the intersection of wildlife conservation, public health, and veterinary science. With increasing awareness of the intricate connections between human health, animal health, and environmental integrity, the market has seen significant growth in recent years. One of the primary drivers of this expansion is the recognition of the threats posed by zoonotic diseases, which can jump from animals to humans, as evidenced by outbreaks such as Ebola, SARS, and most notably, the COVID-19 pandemic. Consequently, there's been a surge in demand for wildlife health products and services aimed at monitoring, diagnosing, and managing diseases in wild animal populations. This includes technologies for disease surveillance, such as remote sensing devices and molecular diagnostics, as well as innovative vaccines and therapeutics tailored to wildlife species.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 2.45 Billion
Market Size 2029USD 4.06 Billion
CAGR 2024-20298.75%
Fastest Growing SegmentMammals
Largest MarketNorth America

There's been a paradigm shift towards a holistic One Health approach, which emphasizes the interconnectedness of human, animal, and environmental health. This approach underscores the importance of preserving biodiversity and ecosystem integrity as key components of disease prevention and control. As a result, the Global Wildlife Health Market encompasses not only biomedical interventions but also ecosystem management strategies, such as habitat restoration, wildlife conservation, and wildlife trade regulation.

The market is characterized by a diverse array of stakeholders, including government agencies, non-profit organizations, research institutions, pharmaceutical companies, and wildlife conservation groups, all of which play crucial roles in shaping policies, funding research, and implementing interventions. However, the market also faces challenges, including funding constraints, regulatory hurdles, and the inherent complexities of working with diverse wildlife species and ecosystems. Additionally, ethical considerations surrounding wildlife research and management, such as animal welfare and indigenous rights, pose important questions that require careful deliberation.

Key Market Drivers

Increasing Zoonotic Disease Threats

Increasing zoonotic disease threats are driving the growth of the Global Wildlife Health Market, as the interconnectedness of human, animal, and environmental health becomes more apparent. Zoonotic diseases, which originate in animals and can be transmitted to humans, pose significant public health risks and economic burdens. Events such as the Ebola outbreak in Africa, the SARS epidemic, and the ongoing COVID-19 pandemic have highlighted the urgency of understanding and managing diseases in wildlife populations to prevent spillover into humans.

As zoonotic diseases continue to emerge and spread, there is a growing recognition of the need for proactive measures to monitor and control wildlife health. This heightened awareness has spurred investment in wildlife health research, surveillance, and interventions aimed at reducing the risk of future pandemics. Governments, non-profit organizations, research institutions, and pharmaceutical companies are allocating resources towards developing innovative solutions for wildlife disease detection, diagnosis, and management.

Technological advancements play a crucial role in enhancing our ability to monitor wildlife health and detect emerging infectious diseases. Remote sensing technologies, such as satellite imagery and unmanned aerial vehicles (UAVs), enable researchers to track changes in habitat and behavior patterns that may indicate disease outbreaks. Molecular diagnostics and genomic sequencing have revolutionized our ability to identify pathogens and trace their transmission pathways, facilitating early detection and response efforts. Additionally, advances in vaccine development and delivery systems hold promise for protecting wildlife populations from infectious diseases.

The increasing threat of zoonotic diseases has also led to a shift in public attitudes towards wildlife conservation and ecosystem health. There is a growing recognition of the importance of preserving biodiversity and ecosystem integrity as essential components of disease prevention and control. This holistic perspective, known as the One Health approach, emphasizes the interconnectedness of human, animal, and environmental health and underscores the need for interdisciplinary collaboration to address complex health challenges.

Technological Advancements

Technological advancements are playing a pivotal role in boosting the Global Wildlife Health Market, revolutionizing the way researchers monitor, diagnose, and manage diseases in wild animal populations. These advancements are driving innovation in wildlife health research, surveillance, and interventions, ultimately contributing to the preservation of biodiversity and the protection of human and animal health. One of the most significant technological advancements in wildlife health is the development of remote sensing technologies. Satellite imagery and unmanned aerial vehicles (UAVs) allow researchers to monitor wildlife populations from a distance, providing valuable insights into habitat use, migration patterns, and population dynamics. These tools enable early detection of changes in wildlife health indicators, such as altered behavior or habitat degradation, which may signal the presence of infectious diseases.

In addition to remote sensing, molecular diagnostics and genomic sequencing have transformed our ability to identify pathogens and track disease transmission pathways in wildlife populations. Rapid advances in DNA sequencing technologies have made it possible to rapidly sequence the genomes of viruses, bacteria, and other pathogens, facilitating the development of targeted diagnostic tests and vaccines. These tools are essential for detecting emerging infectious diseases in wildlife and understanding their potential risks to human and animal health.

Advances in vaccine development and delivery systems hold promise for protecting wildlife populations from infectious diseases. Novel vaccine formulations, such as oral vaccines and DNA vaccines, offer new strategies for immunizing wild animal populations against infectious diseases. These vaccines can be distributed via bait stations or deployed using drone technology, enabling large-scale vaccination campaigns in remote or inaccessible areas.

Technological advancements are also driving innovation in wildlife health monitoring and surveillance. Integrated sensor networks, equipped with environmental sensors, GPS trackers, and health monitoring devices, provide real-time data on wildlife health and behavior. Machine learning algorithms and artificial intelligence systems analyze large datasets to identify patterns and detect anomalies, enabling early warning systems for disease outbreaks.

Growing One Health Approach

The growing adoption of the One Health approach is significantly boosting the Global Wildlife Health Market, as it emphasizes the interconnectedness of human, animal, and environmental health. This holistic perspective recognizes that the health of humans, animals, and ecosystems are intricately linked, and addresses health challenges through collaborative, interdisciplinary efforts.

One of the key drivers behind the increasing adoption of the One Health approach is the recognition of the role of wildlife in the emergence and spread of infectious diseases. Zoonotic diseases, which originate in animals and can be transmitted to humans, pose significant public health risks. Events such as the Ebola outbreak in Africa, the SARS epidemic, and the ongoing COVID-19 pandemic have underscored the importance of understanding and managing diseases in wildlife populations to prevent spillover into humans.

The One Health approach emphasizes the importance of preserving biodiversity and ecosystem integrity as essential components of disease prevention and control. Healthy ecosystems provide essential services, such as regulating infectious disease transmission, maintaining clean air and water, and supporting food security and livelihoods. By addressing the underlying drivers of ecosystem degradation and biodiversity loss, such as habitat destruction, climate change, and wildlife trade, the One Health approach aims to reduce the risk of disease emergence and transmission.

The One Health approach encourages collaboration between human health, animal health, and environmental sectors to address complex health challenges. Governments, non-profit organizations, research institutions, and industry stakeholders are increasingly working together to develop integrated solutions for wildlife health management and conservation. This collaborative approach enables the sharing of knowledge, resources, and expertise across disciplines, leading to more effective disease surveillance, diagnosis, and control efforts.

Key Market Challenges

Funding Constraints

One of the primary challenges hindering the Global Wildlife Health Market is funding constraints. Wildlife health research and interventions require significant financial resources, including funding for research projects, fieldwork, equipment, and personnel. However, funding for wildlife health initiatives is often limited, with competing priorities for public and private sector funding. As a result, many wildlife health programs face budgetary constraints, limiting their capacity to conduct research, monitor wildlife populations, and implement disease control measures effectively.

Regulatory Hurdles

Regulatory hurdles pose significant challenges to the development and implementation of wildlife health interventions. Wildlife health research often involves working with protected species and sensitive ecosystems, requiring compliance with a complex array of regulations and permitting requirements. Obtaining permits for research activities can be time-consuming and costly, leading to delays in project implementation. Additionally, regulatory frameworks for wildlife health may vary between countries and regions, creating inconsistencies and barriers to collaboration across borders.

Data Limitations

Data limitations present challenges to wildlife health research and surveillance efforts. Gathering data on wildlife populations, including population sizes, distribution patterns, and health status, can be logistically challenging, particularly for species that are elusive or occur in remote or inaccessible areas. Additionally, data on wildlife diseases may be limited, particularly for emerging or understudied pathogens. As a result, there may be gaps in our understanding of disease dynamics in wildlife populations, hindering efforts to assess and mitigate health risks.

Key Market Trends

Rising Awareness of Zoonotic Disease Threats

The rising awareness of zoonotic disease threats is significantly boosting the Global Wildlife Health Market, prompting increased investment in wildlife health research, surveillance, and interventions. Zoonotic diseases, which originate in animals and can be transmitted to humans, pose significant public health risks and economic burdens. Events such as the Ebola outbreak in Africa, the SARS epidemic, and the ongoing COVID-19 pandemic have underscored the urgency of understanding and managing diseases in wildlife populations to prevent spillover into humans.

As zoonotic diseases continue to emerge and spread, there is growing recognition of the need for proactive measures to monitor and control wildlife health. This heightened awareness has spurred investment from governments, non-profit organizations, research institutions, and pharmaceutical companies towards developing innovative solutions for wildlife disease detection, diagnosis, and management.

The recognition of zoonotic disease threats has led to a paradigm shift towards a One Health approach, which emphasizes the interconnectedness of human, animal, and environmental health. This holistic perspective underscores the importance of preserving biodiversity and ecosystem integrity as essential components of disease prevention and control. As a result, there is growing investment in wildlife conservation efforts, habitat restoration, and sustainable wildlife management practices, all of which contribute to the health and well-being of both wildlife and human populations.

Technological advancements play a crucial role in enhancing our ability to monitor wildlife health and detect emerging infectious diseases. Remote sensing technologies, such as satellite imagery and unmanned aerial vehicles (UAVs), enable researchers to track changes in habitat and behavior patterns that may indicate disease outbreaks. Molecular diagnostics and genomic sequencing have revolutionized our ability to identify pathogens and trace their transmission pathways, facilitating early detection and response efforts. Additionally, advances in vaccine development and delivery systems hold promise for protecting wildlife populations from infectious diseases.

Increasing Public and Private Investments

Increasing public and private investments are playing a crucial role in boosting the Global Wildlife Health Market, driving advancements in research, surveillance, and interventions aimed at protecting wildlife populations and mitigating the risks of zoonotic disease transmission. Governments, non-profit organizations, research institutions, and pharmaceutical companies are allocating resources towards wildlife health research, surveillance, and conservation initiatives. Public sector investments support projects aimed at preventing, detecting, and responding to emerging infectious diseases in wildlife and humans. For example, initiatives such as the United States Agency for International Development's (USAID) Emerging Pandemic Threats Program and the World Health Organization's (WHO) Global Outbreak Alert and Response Network (GOARN) provide financial support for wildlife health research and capacity-building efforts in regions vulnerable to zoonotic disease outbreaks.

Private sector investment in wildlife health research and product development is driving innovation and facilitating the commercialization of wildlife health products and services. Pharmaceutical companies are investing in the development of vaccines and therapeutics tailored to wildlife species, as well as diagnostic tools and surveillance technologies for monitoring wildlife health. Additionally, companies involved in wildlife conservation and ecotourism are investing in initiatives aimed at protecting wildlife habitats and promoting sustainable wildlife management practices.

The increasing public and private investments in the Global Wildlife Health Market are fueled by growing recognition of the economic, ecological, and public health impacts of wildlife diseases. Zoonotic diseases, which can jump from animals to humans, pose significant risks to human health, livelihoods, and economies. Events such as the Ebola outbreak in Africa, the SARS epidemic, and the ongoing COVID-19 pandemic have underscored the importance of understanding and managing diseases in wildlife populations to prevent spillover into humans.

Investments in wildlife health research and interventions are driven by a desire to preserve biodiversity and ecosystem integrity. Healthy ecosystems provide essential services, such as regulating infectious disease transmission, maintaining clean air and water, and supporting food security and livelihoods. By investing in wildlife health, stakeholders are contributing to the preservation of biodiversity and the protection of human and animal health for future generations.

Segmental Insights

Animal Type Insights

Based on the animal type, mammals segment emerged as the dominant segment in the global wildlife health market in 2023. Mammals serve as reservoirs for many zoonotic diseases, posing significant risks to human health. Diseases such as rabies, Ebola, and COVID-19 have all been transmitted from mammals to humans, underscoring the importance of monitoring and managing health issues in mammalian populations. Additionally, mammals play crucial roles in ecosystem dynamics and functioning. As keystone species, mammals influence the structure and function of ecosystems through their interactions with other species and their roles as predators, prey, and seed dispersers.

Product Insights

Based on the product, medicine segment emerged as the dominant segment in the global wildlife health market in 2023. This dominance can be attributed to the increasing demand for pharmaceutical interventions aimed at addressing wildlife health issues. The rise in zoonotic disease threats, habitat degradation, and climate change-related stressors has led to an urgent need for medicines to treat and prevent diseases in wildlife populations. Pharmaceutical companies are investing in the development of vaccines, antibiotics, antiparasitic drugs, and other therapeutics tailored to wildlife species.

Regional Insights

North America emerged as the dominant region in the Global Wildlife Health Market in 2023, holding the largest market share. North America boasts advanced healthcare infrastructure and a robust research ecosystem, comprising leading universities, research institutions, and pharmaceutical companies dedicated to wildlife health. This research infrastructure enables the development of cutting-edge technologies, diagnostic tools, and pharmaceutical interventions tailored to address wildlife health issues effectively.

Key Market Players

Boehringer Ingelheim International GmbH

NexGen Pharmaceuticals LLC

Virbac S.A.

Dong Bang Co., Ltd.

Pneu-Dart Inc.

DANiNJECT

Genia Inc.

Wedgewood Pharmacy LLC

The Pet Apothecary

Taylors Pharmacy LLC

Report Scope:

In this report, the Global Wildlife Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wildlife Health Market, By Animal Type:

    Mammals Birds Fish Reptiles Amphibians

Wildlife Health Market, By Product:

    Medicine Equipment & Consumables

Wildlife Health Market, By Route of Administration:

    Oral Injectables Others

Wildlife Health Market, By End Use:

    Zoos Wildlife Sanctuaries Wildlife Rescue & Rehab Centers Others

Wildlife Health Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia-Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wildlife Health Market.

Available Customizations:

Global Wildlife Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wildlife Health Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal Type (Mammals, Birds, Fish, Reptiles, Amphibians)
    • 5.2.2. By Product (Medicine, Equipment & Consumables)
    • 5.2.3. By Route of Administration (Oral, Injectables, Others)
    • 5.2.4. By End-Use (Zoos, Wildlife Sanctuaries, Wildlife Rescue & Rehab Centers, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2023)
  • 5.3. Market Map
    • 5.3.1. By Animal Type
    • 5.3.2. By Product
    • 5.3.3. By Route of Administration
    • 5.3.4. By End Use
    • 5.3.5. By Region

6. Asia Pacific Wildlife Health Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal Type
    • 6.2.2. By Product
    • 6.2.3. By Route of Administration
    • 6.2.4. By End-Use
    • 6.2.5. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Wildlife Health Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Route of Administration
        • 6.3.1.2.4. By End-Use
    • 6.3.2. India Wildlife Health Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Route of Administration
        • 6.3.2.2.4. By End-Use
    • 6.3.3. Australia Wildlife Health Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Route of Administration
        • 6.3.3.2.4. By End-Use
    • 6.3.4. Japan Wildlife Health Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Animal Type
        • 6.3.4.2.2. By Product
        • 6.3.4.2.3. By Route of Administration
        • 6.3.4.2.4. By End-Use
    • 6.3.5. South Korea Wildlife Health Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Animal Type
        • 6.3.5.2.2. By Product
        • 6.3.5.2.3. By Route of Administration
        • 6.3.5.2.4. By End-Use

7. Europe Wildlife Health Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal Type
    • 7.2.2. By Product
    • 7.2.3. By Route of Administration
    • 7.2.4. By End-Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Wildlife Health Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By End-Use
    • 7.3.2. Germany Wildlife Health Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By End-Use
    • 7.3.3. Spain Wildlife Health Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By End-Use
    • 7.3.4. Italy Wildlife Health Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Route of Administration
        • 7.3.4.2.4. By End-Use
    • 7.3.5. United Kingdom Wildlife Health Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Route of Administration
        • 7.3.5.2.4. By End-Use

8. North America Wildlife Health Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal Type
    • 8.2.2. By Product
    • 8.2.3. By Route of Administration
    • 8.2.4. By End-Use
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Wildlife Health Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By End-Use
    • 8.3.2. Mexico Wildlife Health Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By End-Use
    • 8.3.3. Canada Wildlife Health Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By End-Use

9. South America Wildlife Health Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type
    • 9.2.2. By Product
    • 9.2.3. By Route of Administration
    • 9.2.4. By End-Use
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Wildlife Health Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By End-Use
    • 9.3.2. Argentina Wildlife Health Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By End-Use
    • 9.3.3. Colombia Wildlife Health Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By End-Use

10. Middle East and Africa Wildlife Health Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type
    • 10.2.2. By Product
    • 10.2.3. By Route of Administration
    • 10.2.4. By End-Use
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Wildlife Health Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By End-Use
    • 10.3.2. Saudi Arabia Wildlife Health Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By End-Use
    • 10.3.3. UAE Wildlife Health Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By End-Use
    • 10.3.4. Egypt Wildlife Health Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Animal Type
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Route of Administration
        • 10.3.4.2.4. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches (If Any)
  • 12.3. Mergers & Acquisitions (If Any)

13. Global Wildlife Health Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Boehringer Ingelheim International GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. NexGen Pharmaceuticals LLC
  • 15.3. Virbac S.A.
  • 15.4. Dong Bang Co., Ltd.
  • 15.5. Pneu-Dart Inc.
  • 15.6. DANiNJECT
  • 15.7. Genia Inc.
  • 15.8. Wedgewood Pharmacy LLC
  • 15.9. The Pet Apothecary
  • 15.10. Taylors Pharmacy LLC

16. Strategic Recommendations

17. About Us & Disclaimer